Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China · Delayed Price · Currency is CNY

6.27

+0.07 (1.13%)

Feb 3, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Anti-tumor Drug	703.97M
Anti-tumor Drug Growth	-16.98%
Traditional Chinese Medicine Cough Relief	292.46M
Traditional Chinese Medicine Cough Relief Growth	33.77%
Three High Chronic Disease Product	106.71M
Three High Chronic Disease Product Growth	14.14%
Skin External Antibacterial	89.89M
Skin External Antibacterial Growth	-10.82%
Miao Medicine Muscle and Bone Strengthening	89.05M
Miao Medicine Muscle and Bone Strengthening Growth	8.33%
Classic Tonic Product	50.47M
Classic Tonic Product Growth	10.11%
Magic Baby Medicine	30.85M
Magic Baby Medicine Growth	-12.32%
Other	977.55M
Other Growth	1.35%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	2.34B
China Growth	-2.00%